TEMPLE, a Phase 3 multicenter, randomized, double-blind, head-to-head study, evaluated the tolerability, safety and efficacy of atogepant compared to topiramate for the preventive treatment of migraine in adult patients with… Read More
UBC Faculty of Medicine researchers have been awarded more than $6.5 million from Brain Canada’s Platform Support Grants program to support two innovative neuroscience research platforms. The funding will help… Read More
Debiopharm taps ViewsML’s AI-driven platform to streamline biomarker detection in oncology research. VANCOUVER, BC – ViewsML, a techbio company specializing in AI-driven virtual staining and biomarkers for precision medicine and diagnostics, has announced… Read More
EDMONTON, AB – GlycoNet, Canada’s national network advancing glycomics research and innovation, signed a memorandum of understanding (MOU) with Japan’s Institute for Glyco-core Research (iGCORE) during the Glyco27 conference in Edmonton. The… Read More
As a leader in cell therapy development and clinical manufacturing, Leela will play a key role in advancing Aspect’s therapeutic pipeline VANCOUVER, BC – Aspect Biosystems, a biotechnology company pioneering… Read More
